Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy
© 2018 Royal Pharmaceutical Society Objectives: Pigment epithelium-derived factor (PEDF), a multifunctional endogenous glycoprotein, has a very wide range of biological actions, notably in bone homeostasis. The question has been raised regarding the place of PEDF in the treatment of bone disorders a...
| Main Authors: | , |
|---|---|
| Format: | Journal Article |
| Published: |
John Wiley & Sons Ltd.
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/73327 |
| _version_ | 1848762985074393088 |
|---|---|
| author | Baxter-Holland, M. Dass, Crispin |
| author_facet | Baxter-Holland, M. Dass, Crispin |
| author_sort | Baxter-Holland, M. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | © 2018 Royal Pharmaceutical Society Objectives: Pigment epithelium-derived factor (PEDF), a multifunctional endogenous glycoprotein, has a very wide range of biological actions, notably in bone homeostasis. The question has been raised regarding the place of PEDF in the treatment of bone disorders and osteosarcoma, and its potential for tumour growth suppression. Methods: The PubMed database was used to compile this review. Key findings: Pigment epithelium-derived factor's actions in osteoid tissues include promoting mesenchymal stem cell commitment to osteoblasts, increasing matrix mineralisation, and promoting osteoblast proliferation. It shows potential to improve therapeutic outcomes in treatment of multiple cancer types and regrowth of bone after trauma or resection in animal studies. PEDF may possibly have a reduced adverse effect profile compared with current osteo-regenerative treatments; however, there is currently very limited evidence regarding the safety or efficacy in human models. Summary: Pigment epithelium-derived factor is very active within the body, particularly in osseous tissue, and its physiological actions give it potential for treatment of both bone disorders and multiple tumour types. Further research is needed to ascertain the adverse effects and safety profile of PEDF as a therapeutic agent. |
| first_indexed | 2025-11-14T10:56:15Z |
| format | Journal Article |
| id | curtin-20.500.11937-73327 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T10:56:15Z |
| publishDate | 2018 |
| publisher | John Wiley & Sons Ltd. |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-733272018-12-13T09:35:22Z Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy Baxter-Holland, M. Dass, Crispin © 2018 Royal Pharmaceutical Society Objectives: Pigment epithelium-derived factor (PEDF), a multifunctional endogenous glycoprotein, has a very wide range of biological actions, notably in bone homeostasis. The question has been raised regarding the place of PEDF in the treatment of bone disorders and osteosarcoma, and its potential for tumour growth suppression. Methods: The PubMed database was used to compile this review. Key findings: Pigment epithelium-derived factor's actions in osteoid tissues include promoting mesenchymal stem cell commitment to osteoblasts, increasing matrix mineralisation, and promoting osteoblast proliferation. It shows potential to improve therapeutic outcomes in treatment of multiple cancer types and regrowth of bone after trauma or resection in animal studies. PEDF may possibly have a reduced adverse effect profile compared with current osteo-regenerative treatments; however, there is currently very limited evidence regarding the safety or efficacy in human models. Summary: Pigment epithelium-derived factor is very active within the body, particularly in osseous tissue, and its physiological actions give it potential for treatment of both bone disorders and multiple tumour types. Further research is needed to ascertain the adverse effects and safety profile of PEDF as a therapeutic agent. 2018 Journal Article http://hdl.handle.net/20.500.11937/73327 10.1111/jphp.12942 John Wiley & Sons Ltd. restricted |
| spellingShingle | Baxter-Holland, M. Dass, Crispin Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy |
| title | Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy |
| title_full | Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy |
| title_fullStr | Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy |
| title_full_unstemmed | Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy |
| title_short | Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy |
| title_sort | pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy |
| url | http://hdl.handle.net/20.500.11937/73327 |